Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Nov 15, 2021 · 10-Q · 46 days after period end · 0001069530-21-000050
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Net Income | -$9.56M | -$1.43M | -$697.00K | -$1.27M |
| EPS Diluted | -$0.24 | -$0.06 | -$0.04 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end
